Breast Cancer News and Research

Latest Breast Cancer News and Research

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Interferon gamma identified as one of the signaling proteins involved with tumor relapse

Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse.

13 Mar 2007

Study aims to find which breast cancer patients need chemotherapy

Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.

13 Mar 2007

University of Miami, Haitian Community health workers team up to address breast cancer

A collaboration between doctors at the University of Miami and members of the Haitian community in Southern Florida is attempting to address mammography screening and breast cancer among Haitian women living in the U.S., the Miami Herald reports.

11 Mar 2007

Computer key unlocks cancer, multiple sclerosis, and Alzheimer's disease

Danish and Belgian researchers have found a computer key that maps genes underlying heritable disorders, such as breast cancer, multiple sclerosis, and Alzheimer's disease. These results will possibly ease the discovery of new medicines and improve treatment in various disorders.

8 Mar 2007

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research has announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers anti-cancer antibodies in ARIUS' partnered program for melanoma, breast and prostate cancers and protects the valuable site on the disease target that the drug candidate binds to.

8 Mar 2007

Women from poor backgrounds fare worse with breast cancer

Women from more deprived backgrounds have worse treatment and a lower breast cancer survival rate than their more affluent counterparts - according to a new study published by Cancer Research UK in the British Journal of Cancer.

7 Mar 2007

Effect of depression in mothers with breast cancer on their children's concerns

A woman's breast cancer diagnosis can wreak as much havoc on her emotions as it does on her physical health. Mothers who experience bouts of depression during their battles with breast cancer may find that the effects reach beyond their own psyches to those of their children.

5 Mar 2007

Life-saving cancer genetic testing vastly underutilized

A study released today at the Society of Gynecologic Oncologists 38th Annual Meeting on Women's Cancer found few patients were aware of genetic cancer syndromes and the high risk of developing cancer if genetic mutations were found. Fewer still were motivated to follow up on this information with their own healthcare provider or genetic counseling/testing services.

5 Mar 2007

Obesity epidemic fuelling premature puberty in girls

Researchers in the United States say girls who are overweight at the age of three run the risk of reaching puberty as early as nine years old and warn that the obesity crisis is now affecting children's development.

5 Mar 2007

Industry funded studies on breast cancer treatments more likely to have positive results

Industry-funded clinical trials of breast cancer medications report more favorable results than nonindustry supported research, according to a study published in the Feb. 26 online edition of the journal Cancer, the New York Times reports (Bakalar, New York Times, 2/27).

28 Feb 2007

Cancer Research UK secures fenretinide orphan drug licence

A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).

27 Feb 2007

Drug industry influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

27 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

Financial interest of drug industry influences research results

According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.

26 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

26 Feb 2007

Hormone patch could be safer than pills in relieving the symptoms of the menopause

According to new research by French scientists hormone skin patches and gels are far less likely than pills to cause dangerous blood clots.

26 Feb 2007

Research defines the cancer role for protein Gab-2

A protein known for its ability to "bridge" interactions between other cellular proteins may spur metastasis in breast cancer, the disease's deadliest stage, a study from Burnham Institute for Medical Research has found.

22 Feb 2007

Why are African American women more likely than White women to die from breast cancer?

Why are African American women 1.5 to 2.2 times more likely than White women to die from breast cancer, despite their lower incidence of the disease? Is it solely because they have less access to medical care? Maybe not, according to a new analysis that will appear in an upcoming issue of the International Journal of Surgery.

22 Feb 2007

New understanding of how and why Taxol works in patients with breast cancer

Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

22 Feb 2007

Breast Cancer News and Research

Latest Breast Cancer News and Research

Tykerb (lapatinib) - new anti-cancer treatment approved

Interferon gamma identified as one of the signaling proteins involved with tumor relapse

Study aims to find which breast cancer patients need chemotherapy

University of Miami, Haitian Community health workers team up to address breast cancer

Computer key unlocks cancer, multiple sclerosis, and Alzheimer's disease

ARIUS Research granted two new U.S. patents for antibodies

Women from poor backgrounds fare worse with breast cancer

Effect of depression in mothers with breast cancer on their children's concerns

Life-saving cancer genetic testing vastly underutilized

Obesity epidemic fuelling premature puberty in girls

Industry funded studies on breast cancer treatments more likely to have positive results

Cancer Research UK secures fenretinide orphan drug licence

Drug industry influences breast cancer research

Stimuvax investigational lung cancer vaccine phase III study starts

Financial interest of drug industry influences research results

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

Hormone patch could be safer than pills in relieving the symptoms of the menopause

Research defines the cancer role for protein Gab-2

Why are African American women more likely than White women to die from breast cancer?

New understanding of how and why Taxol works in patients with breast cancer

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in